Sancy Leachman, a professor at the University of Utah, is the director of the Melanoma and Cutaneous Oncology Program at Huntsman Cancer Institute. Her research applies molecular-level insights to patient care and emphasizes the use of human genetics in the prevention and treatment of disease. Leachman has assembled and studied one of the largest and best-characterized hereditary melanoma populations in the world. She developed and published international consensus guidelines for melanoma genetic testing in this population and is currently developing genetic counseling strategies to help patients avoid the disease. Leachman founded the International Pachyonychia Congenita Consortium and led a first-in-human mutation-targeted siRNA Phase Ib trial for this inherited skin disorder. A graduate of the University of Texas at Austin, Leachman received her medical degree and a Ph.D. at the University of Texas Southwestern Medical School and completed her dermatologic training at Yale.

Panel:
Cancer Prevention: What Will It Take?